...mutations and present many mutation-associated neoantigens, which might be recognized by the immune system. Currently, MSI can also be used as a marker to predict the effect of immune therapy (Le et al. 2017). The MSI phenotype is most common in colorectal (CR) cancers, stomach (ST) cancers, and uterine (UT...